Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
having an outbreak; Well she's 19 years old; This non-serious case was reported by a consumer and described the occurrence of herpes zoster in a 19-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced herpes zoster (Verbatim: having an outbreak) and inappropriate age at vaccine administration (Verbatim: Well she's 19 years old). The outcome of the herpes zoster was not reported and the outcome of the inappropriate age at vaccine administration was not applicable. It was unknown if the reporter considered the herpes zoster to be related to Shingrix. It was unknown if the company considered the herpes zoster to be related to Shingrix. Linked case(s) involving the same patient: US2025024809 Additional Information: GSK Receipt Date: 27-FEB-2025 The patient was 19 years old. The other health professional reported that some idiot at a drugstore administered the second shot while the patient was having an outbreak. The patient received first dose of Shingrix outside the recommended age which led to inappropriate age at vaccine administration. For tolerance to 2nd dose, refer case US2025024809.; Sender's Comments: US-GSK-US2025024809:Same patient ,2nd dose